+966-13-849-4382
rbouderhem@pmu.edu.sa
T0-32
Dr. Rabaï Bouderhem was born and raised in France. He is a French national, working as an Assistant Professor in the College of Law at Prince Mohammad Bin Fahd University.
He completed all his studies in law (BA, Master degree and PhD) at the University of Burgundy in Dijon (France).
Dr. Rabaï has several years of experience in teaching, research and curriculum development at undergraduate and graduate levels in different countries (France, Morocco, Uzbekistan, Saudi Arabia). He also has a strong experience in private practice having served as the Legal Director of a London-based company specialized in consultancy.
He is currently a Research Associate at the CREDIMI (Centre de Recherches sur le Droit des Marchés et des Investissements Internationaux, FRE 2003, CNRS/University of Burgundy, Dijon, France).
Dr. Rabaï has presented his research in international conferences (Singapore, Switzerland, Saudi Arabia, UAE, Oman, Morocco) and published several articles in peer-reviewed journals in areas relating to European law, AI regulation, public health and international economic law.
March 2012: PhD in Law, University of Burgundy, Dijon, France.
Peer-Reviewed Articles:
1. Shaping the future of artificial intelligence in healthcare through ethics and governance. Humanities and Social Sciences Communications, (2024). Nature Portfolio. https://www.nature.com/articles/s41599-024-02894-w (Q1, WoS SSCI, IF 3.5).
2. A review of Saudi e-commerce regulation under the scope of the GDPR. Arab Law Quarterly, Brill (2024) 1-19. https://doi.org/10.1163/15730255-bja10154. (Q3, WoS ESCI, Scopus)
3. Privacy and regulatory issues in wearable health technology. Eng. Proc. 2023, 58, 87. https://doi.org/10.3390/ecsa-10-16206. (Q4, Scopus)
4. International cooperation against cybercrime: the necessity to embrace multilateralism and adopt a United Nations cybercrime convention, International Journal of Development and Conflict, Open Access, 12 (2022), 166-172. (Q4, Scopus)
http://www.ijdc.org.in/uploads/1/7/5/7/17570463/paper_5_dr._rabaï_bouderhem.pdf.
5. Access to COVID-19 vaccines: a new global approach, Vaccines MDPI, Open Access, ISSN: 2076-393X. 25 October 2022. https://doi.org/10.3390/vaccines10111795. (Q1, WoS SCIE, IF 7.8)
6. Access to essential medicines and international health law: towards a new paradigm? (March 30, 2022). Asian Journal of WTO & International Health Law and Policy, Vol. 17, No. 1, pp. 175-200, March 2022. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4072003. (Q4, WoS SSCI)
7. Groups of companies in European comparative law, European Business Law Review, ISSN 0959-6941, Wolters Kluwer, 2/2021, pp. 177-206. https://doi.org/10.54648/eulr2021008. (Q2, Scopus)
8. The legal connection of trading companies in European comparative law, International Business Law Journal (Revue de droit des affaires internationales), 2019/3, pp.287-308, ISSN 1777-5655, Sweet & Maxwell, Thomson Reuters.
9. Recognition and enjoyment of rights by foreign trading companies in French and European law, International Business Law Journal (Revue de droit des affaires internationales), 2018/1, pp. 35-60, ISSN 1777-5655, Sweet & Maxwell, Thomson Reuters.
10. La position des Etats membres de l’Union européenne et les solutions du droit de l’Union européenne en matière de groupes de sociétés, International Business Law Journal (Revue de droit des affaires internationales), 2017/3, pp. 225-252, ISSN 1777-5655, Sweet & Maxwell, Thomson Reuters.
11. La mobilité des sociétés en droit international privé et en droit de l’Union européenne, International Business Law Journal (Revue de droit des affaires internationales), 2014/5, pp. 389-398, ISSN 1777-5655, Sweet & Maxwell, Thomson Reuters.
12. Les conflits de juridictions en matière de sociétés commerciales en droit international privé Français, International Business Law Journal (Revue de droit des affaires internationales), 2014/1, pp. 55-70, ISSN 1777-5655, Sweet & Maxwell, Thomson Reuters.
Conference Papers (Peer-Reviewed):
13. Ethical and regulatory challenges for AI biosensors in healthcare. Proceedings 2024, 104, 37. https://doi.org/10.3390/proceedings2024104037.
14. Challenges faced by states and the WHO in efficiently regulating the use of mRNA vaccines. Med. Sci. Forum 2024, 26, 1. https://doi.org/10.3390/IECV2023-16530.
15. Blockchain technology in healthcare: a possible disruption under the scope of privacy, Proceedings of the MOL2NET'23, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 9th ed., 25–31 December 2023, MDPI: Basel, Switzerland, https://doi.org/10.3390/mol2net-09-16305 (registering DOI). https://sciforum.net/paper/view/16305.
16. AI Regulation in healthcare: new paradigms for a legally binding treaty under the World Health Organization, IEEE Explore, 12 (2022). (Scopus) https://ieeexplore.ieee.org/document/10008303.
Book(s)/Book(s) Chapter(s):
17. La nationalité des sociétés en droit français. Droit. Université de Bourgogne, 2012, ffNNT: 2012DIJOD003ff. fftel-00960318f. https://tel.archives-ouvertes.fr/tel-00960318 (PhD thesis). (16200+ downloads)
Conferences:
18. Regulating the use of AI in mRNA vaccine development through policy coherence, The 2nd International Electronic Conference on Vaccines, Part of the International Electronic Conference on Vaccines series, 27–29 Nov. 2024, MDPI: Basel, Switzerland. https://sciforum.net/event/IECV2024
19. A comprehensive framework for transparent and explainable AI sensors in healthcare, 11th International Electronic Conference on Sensors and Applications, Part of the International Electronic Conference on Sensors and Applications series, 26–28 Nov. 2024, MDPI: Basel, Switzerland. https://sciforum.net/event/ecsa-11.
20. Ethical implications of AI systems in bioengineering research, The 1st International Online Conference on Bioengineering, Bioengineering in a Generative AI World, 16–18 Oct. 2024, MDPI: Basel, Switzerland. https://sciforum.net/event/IOCBE2024.
21. Measuring the impact of policy coherence on energy efficiency in developing countries, World Energy Justice Congress 2024, organized by the Energy Justice & the Social Contract Chair and the Ecole Centrale Casablanca, 27-30 May 2024, Casablanca, Morocco. https://wejc.sciencesconf.org/
22. Ethical and regulatory challenges for AI biosensors in healthcare, IECB 2024, The 4th International Electronic Conference on Biosensors, Part of the International Electronic Conference on Biosensors series, 20–22 May 2024, MDPI: Basel, Switzerland. https://sciforum.net/event/IECB2024.
23. Blockchain technology in healthcare: a possible disruption under the scope of privacy, MOL2NET'23, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 9th ed., 25–31 December 2023, MDPI: Basel, Switzerland. https://mol2net-09.sciforum.net.
24. Challenges faced by states and the WHO in regulating efficiently the use of mRNA vaccines, The 1st International Electronic Conference on Vaccines: RNA Vaccines, Current Challenges and Future Developments, 01-15 December 2023, Vaccines MDPI: Basel, Switzerland. https://iecv2023.sciforum.net.
25. Privacy and regulatory issues in wearable health technology, 10th International Electronic Conference on Sensors and Applications, 15–30 November 2023, MDPI: Basel, Switzerland. https://ecsa-10.sciforum.net.
26. AI regulation in healthcare: new paradigms for a legally binding treaty under the World Health Organization, 14th International Conference on Computational Intelligence and Communication Networks (CICN), Prince Mohammad bin Fahd University, Khobar, Saudi Arabia, 04-06 December 2022. https://cicn2022.org/
27. The WTO joint statement initiative on e-commerce: should multilateralism or plurilateral agreements prevail?, 1st International Conference on Legal Protection for Electronic Transactions, Dhofar University, College of law, Oman, 20-22 December 2022.
28. International cooperation against cybercrime: the necessity to embrace multilateralism and adopt a United Nations cybercrime convention, PMU Conference on Conflict Prevention & Resolution 2022, 10-11 May 2022, Al Khobar, Saudi Arabia. https://pmu.edu.sa/ccpr/default
29. Access to essential medicines and international health law: towards a new paradigm?, 2021 7th Asian International Economic Law Network (AIELN) Conference (Virtual Conference), 9-10 December 2021, Singapore. https://site.smu.edu.sg/7th-asian-international-economic-law-network-aieln-conference
30. Public-private partnerships and corporate social responsibility: towards a new paradigm for sustainable education systems, 4th AFU International Conference (Virtual Conference): Towards Advanced Scientific Knowledge (TASK4 – 2021), 19-20 May 2021, Dubai, United Arab Emirates. https://afu.ac.ae/en/task-2021/
31. Regulating cyberspace: The Saudi national approach to e-commerce & the need of enhanced protection, 2020 PMU International Conference on Industrial Revolution 4.0 in Computing, Mobility, and Manufacturing (CMM 2020), 08-10 December 2020, Khobar, Saudi Arabia. https://cob.pmu.edu.sa/PDF/CMM-2020-PROGRAM-Final.pdf
Other Academic Activities:
- Reviewer, PMU Conference on Conflict Prevention & Resolution 2022, 10-11 May 2022.
- Reviewer, Humanities and Social Sciences Communications, Nature Journal Portfolio.
- Reviewer for SpringerNature (book proposal in the field of AI and health, 2024).
- Member of the Scientific Committee, 1st International Conference on Legal Protection for Electronic Transactions, Dhofar University, College of law, Oman, 20-22 December 2022.
Award(s):
- Best Paper Award (8 August 2024): I have earned the best paper award following my participation in the 1st International Electronic Conference on Vaccines organized by Vaccines MDPI (Web of Science SCIE) for my paper titled 'Challenges faced by states and the WHO in regulating efficiently the use of mRNA vaccines'. https://sciforum.net/event/iecv2023?section=#awards
AI regulation, EU law, private international law, public health and international economic law.